California Public Employees Retirement System’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-22,300
| Closed | -$931K | – | 3049 |
|
2021
Q1 | $931K | Sell |
22,300
-2,034
| -8% | -$84.9K | ﹤0.01% | 2554 |
|
2020
Q4 | $1.13M | Sell |
24,334
-500
| -2% | -$23.3K | ﹤0.01% | 2387 |
|
2020
Q3 | $1.06M | Sell |
24,834
-58
| -0.2% | -$2.46K | ﹤0.01% | 2251 |
|
2020
Q2 | $1.19M | Buy |
24,892
+4,313
| +21% | +$207K | ﹤0.01% | 2111 |
|
2020
Q1 | $947K | Sell |
20,579
-35,695
| -63% | -$1.64M | ﹤0.01% | 2046 |
|
2019
Q4 | $3.38M | Buy |
56,274
+51,395
| +1,053% | +$3.09M | ﹤0.01% | 1715 |
|
2019
Q3 | $276K | Buy |
+4,879
| New | +$276K | ﹤0.01% | 2789 |
|
2018
Q4 | – | Sell |
-2,970
| Closed | -$206K | – | 3272 |
|
2018
Q3 | $206K | Buy |
2,970
+216
| +8% | +$15K | ﹤0.01% | 3013 |
|
2018
Q2 | $208K | Buy |
+2,754
| New | +$208K | ﹤0.01% | 2987 |
|
2016
Q2 | – | Sell |
-8,600
| Closed | -$348K | – | 3573 |
|
2016
Q1 | $348K | Sell |
8,600
-3,900
| -31% | -$158K | ﹤0.01% | 2894 |
|
2015
Q4 | $1.11M | Sell |
12,500
-6,400
| -34% | -$567K | ﹤0.01% | 2318 |
|
2015
Q3 | $1.4M | Buy |
18,900
+8,900
| +89% | +$659K | ﹤0.01% | 2158 |
|
2015
Q2 | $809K | Buy |
+10,000
| New | +$809K | ﹤0.01% | 2632 |
|